FDA's Opioid REMS Proposal

Here is the proposed class-wide REMS developed by FDA and presented to the advisory committee.

The proposed goal for the REMS would be:

• Reduce serious adverse outcomes resulting from inappropriate prescribing, misuse, and abuse of long-acting and extended-release opioids while maintaining patient access to these medications. Adverse outcomes of concern include addiction,...

More from Archive

More from Pink Sheet